Duration of survival in patients with myeloma treated with thalidomide.

Barlogie B, Shaughnessy JD, Crowley J.

DOI: 10.1056/nejmc0801352
Published: 2008-07-01
Container: N Engl J Med
Publisher: Not recorded
Open access: no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmc0801352,
  title = {Duration of survival in patients with myeloma treated with thalidomide.},
  author = {Barlogie B and  Shaughnessy JD and  Crowley J.},
  year = {2008},
  journal = {N Engl J Med},
  doi = {10.1056/nejmc0801352},
  url = {https://doi.org/10.1056/nejmc0801352}
}

RIS

TY  - JOUR
TI  - Duration of survival in patients with myeloma treated with thalidomide.
AU  - Barlogie B
AU  -  Shaughnessy JD
AU  -  Crowley J.
PY  - 2008
JO  - N Engl J Med
DO  - 10.1056/nejmc0801352
UR  - https://doi.org/10.1056/nejmc0801352
ER  -

APA

B, B., JD, S., & J., C. (2008). Duration of survival in patients with myeloma treated with thalidomide.. N Engl J Med. https://doi.org/10.1056/nejmc0801352

Source records

europe-pmc · retrieved 2026-09-25T05:15:28.116Z